1. General Understanding of Disease

Understanding the state of knowledge of pathogenesis of IBD, and the principles underlying treatment


Full content only available after log-in


1.1. Knows the science underlying the pathogenesis of IBD, in particular relating to genetic and environmental factors involved, and differences between ulcerative colitis (UC) , Crohn’s disease (CD) and IBD unclassified

1.2. Understands the natural history of UC and Crohn’s disease, including its variability and the impact of therapy on the natural history

1.3. Understands the importance of communicating with patients and educating them about their disease and its natural history as well as the principals of management

1.4. Understands the basic immunology of IBD and mechanism of action (as far as it is understood) and rationale for using different treatment types in IBD

1.5. Able to use knowledge of modifiable and non-modifiable risk factors to underlie management decisions and to stratify risk for patients


        
 
Topic:





Programme Phase:



Content Format:








Page: () 1 2 3 4 5 6 7 ()

Topic 1.1 :

Abstract 1: Developing a colorectal cancer risk prediction tool for patients with Ulcerative Colitis and low grade dysplasia

M. Kabir

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Abstract 1: Developing a colorectal cancer risk prediction tool for patients with Ulcerative Colitis and low grade dysplasia

M. Kabir

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Abstract 2: Gene expression profiles in inflamed colonic biopsies from newly diagnosed Crohn's Disease and Ulcerative Colitis patients differ depending on the age at diagnosis

S. Verstockt

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Abstract 5: Targeting fibroblast activation protein in Crohn's Disease intestinal strictures restores balanced deposition of extracellular matrix and reduces fibrosis

M. Truffi

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Angiogenesis and lymphangiogenesis in mesenteric adipose tissue in IBD

S. Danese

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Fat and mesenchymal cell interactions - Role in fibrosis and creeping fat formation

R. Mao

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Fat: Unsuspected modulator of response to therapy

S. Subramanian

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Hot topics in IBD research

M. Svrcek

ECCO'18 Vienna

PPT
 


Topic 1.1 :

How the gut speaks to the liver: Novel insights from PSC pathogenesis

H. Tilg

ECCO'18 Vienna

Webcast + PPT
 


Topic 1.1 :

Molecular basis of dysplasia in IBD ? clues for cancer prevention therapies?

L. Egan

ECCO'18 Vienna

Webcast + PPT
 


Page: () 1 2 3 4 5 6 7 ()